Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial

Cédric Draulans, Karin Haustermans, Floris J. Pos, Uulke A. van der Heide, Lisa De Cock, Jochem van der Voort van Zyp, Hans de Boer, Robert Jan Smeenk, Martina Kunze-Busch, Evelyn M. Monninkhof, Robin De Roover, Sofie Isebaert, Linda G.W. Kerkmeijer